002793 羅欣藥業
按盤價 
4.450 +0.380 (+9.337%)
4.450 +0.380 (+9.337%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -3.733 | -23.425 | -32.408 | 9.637 | 8.306 |
| 總資產報酬率 ROA (%) | -1.711 | -9.990 | -13.907 | 4.716 | 4.246 |
| 投入資產回報率 ROIC (%) | -2.056 | -11.791 | -16.802 | 6.042 | 5.693 | 邊際利潤分析 |
| 銷售毛利率 (%) | 40.202 | 46.278 | 26.741 | 50.190 | 53.637 |
| 營業利潤率 (%) | -9.449 | -24.810 | -40.667 | 7.360 | 6.957 |
| 息稅前利潤/營業總收入 (%) | -6.492 | -22.876 | -37.463 | 8.967 | 7.309 |
| 淨利潤/營業總收入 (%) | -9.640 | -32.528 | -35.046 | 6.509 | 5.593 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 119.314 | 72.963 | 111.686 | 108.534 | 113.390 |
| 價值變動淨收益/利潤總額(%) | 6.017 | -1.902 | -11.182 | -0.671 | 0.079 |
| 營業外收支淨額/利潤總額(%) | -7.896 | 2.919 | 0.274 | 1.740 | -4.126 | 償債能力分析 |
| 流動比率 (X) | 0.913 | 1.078 | 1.079 | 1.589 | 1.646 |
| 速動比率 (X) | 0.710 | 0.841 | 0.923 | 1.412 | 1.428 |
| 資產負債率 (%) | 55.226 | 49.732 | 59.265 | 50.133 | 0.437 |
| 帶息債務/全部投入資本 (%) | 45.080 | 36.200 | 51.356 | 39.439 | 29.693 |
| 股東權益/帶息債務 (%) | 113.888 | 163.149 | 87.912 | 147.289 | 230.988 |
| 股東權益/負債合計 (%) | 78.688 | 97.049 | 65.983 | 92.093 | 119.893 |
| 利息保障倍數 (X) | -2.865 | -8.536 | -11.299 | 6.070 | 11.634 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 67.933 | 104.563 | 200.819 | 157.074 | 134.628 |
| 存貨周轉天數 (天) | 116.941 | 161.670 | 95.476 | 75.613 | 88.348 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
